Evidence map›Paper›PMID 25684206›Full record

ArticleMolecular cell2015

A specific LSD1/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation.

Benoit Laurent, Lv Ruitu, Jernej Murn, Kristina Hempel, Ryan Ferrao, Yang Xiang, Shichong Liu, Benjamin A Garcia, Hao Wu, Feizhen Wu and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 159 papers.

0numbers the graph read from it
0cells of the map it votes in
159citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

159 citing papers in PubMed, 278 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Discovery and structural studies of histone demethylases.Frontiers in epigenetics and epigenomics · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

99 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Benoit LaurentDivision of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children's Hospital, Boston MA, 02115, USA; Department of Cell Biology, Harvard Medical School, Boston MA, 02115, USA.
Lv RuituDepartment of Biochemistry and Epigenetics Laboratory, Institute of Biomedical Sciences, Fudan University, Shanghai 200032, China.
Jernej MurnDivision of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children's Hospital, Boston MA, 02115, USA; Department of Cell Biology, Harvard Medical School, Boston MA, 02115, USA.
Kristina HempelDepartment of Neurology, Harvard Medical School, Boston, MA 02115, USA; Proteomics Center, Boston Children's Hospital, Boston, MA 02115, USA.
Ryan FerraoDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA.
Yang XiangDivision of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children's Hospital, Boston MA, 02115, USA; Department of Cell Biology, Harvard Medical School, Boston MA, 02115, USA.
Shichong LiuDepartment of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Benjamin A GarciaDepartment of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Hao WuDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA.
Feizhen WuDepartment of Biochemistry and Epigenetics Laboratory, Institute of Biomedical Sciences, Fudan University, Shanghai 200032, China.
Hanno SteenProteomics Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Yang ShiDivision of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children's Hospital, Boston MA, 02115, USA; Department of Cell Biology, Harvard Medical School, Boston MA, 02115, USA. Electronic address: yang_shi@hms.harvard.edu.
Boston Children's Hospital · USHarvard University · USFudan University · CNUniversity of Pennsylvania · USCornell University · US

Funding

Histone Demethylases and Regulation of Chromatin and Transcription in EukaryotesR01CA118487 · NCI · HARVARD MEDICAL SCHOOL · PI SHI, YANG · 2006 to 2017
$3.6M
Understanding the Role of Combinatorial Histone PTM PatternsR01GM110174 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI GARCIA, BENJAMIN A · 2014 to 2017
$1.3M
NCI NIH HHS R01 CA118487NIGMS NIH HHS R01 GM110174
6 · The paper itself

Abstract

Lysine-specific demethylase 1 (LSD1) has been reported to repress and activate transcription by mediating histone H3K4me1/2 and H3K9me1/2 demethylation, respectively. The molecular mechanism that underlies this dual substrate specificity has remained unknown. Here we report that an isoform of LSD1, LSD1+8a, does not have the intrinsic capability to demethylate H3K4me2. Instead, LSD1+8a mediates H3K9me2 demethylation in collaboration with supervillin (SVIL), a new LSD1+8a interacting protein. LSD1+8a knockdown increases H3K9me2, but not H3K4me2, levels at its target promoters and compromises neuronal differentiation. Importantly, SVIL co-localizes to LSD1+8a-bound promoters, and its knockdown mimics the impact of LSD1+8a loss, supporting SVIL as a cofactor for LSD1+8a in neuronal cells. These findings provide insight into mechanisms by which LSD1 mediates H3K9me demethylation and highlight alternative splicing as a means by which LSD1 acquires selective substrate specificities (H3K9 versus H3K4) to differentially control specific gene expression programs in neurons.

Indexed as

Alternative SplicingCell DifferentiationCell MovementGene Expression RegulationGene Knockdown TechniquesHeLa CellsHistone DemethylasesHistonesHumansLysineMembrane ProteinsMethylationMicrofilament ProteinsNeuronsPromoter Regions, GeneticProtein IsoformsHistone DemethylasesHistonesKDM1A protein, humanLysineMembrane ProteinsMicrofilament ProteinsProtein IsoformsSVIL protein, human

Identifiers

PMID25684206
PMCPMC4369399
OpenAlexW2009089729

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.